Accidentally landed an IB interview…

Alright boys… so I’m at a cross roads. Background about myself. I went to medical school and non target background. I didn’t go to residency and went straight in ER. For the past 4-6 months I’ve been trying to land a biotech ER seat (I’m currently in MedTech). Either it’s me or how the market is, but I’ve had 4 interviews and they didn’t amount to anything.

My family friend landed me a few interviews with some MM IBD shops as an analyst in the HC group. I never really considered IB, bc my career goal is to be at a HF and cover biotech (figured biotech ER is the most direct route to do this. I don’t really see too many IB backgrounds in biotech HF seats given but could be wrong). Should I also start targeting IB seats to get to a HF? What I’m interviewing for right now is HC services IB.

Any advice would be appreciated. Thx

 

Hey there, fellow finance enthusiast! It sounds like you're in quite the pickle, but don't worry, we'll figure this out together.

First off, it's great that you've landed an interview in IB, especially in the HC group. That's a fantastic opportunity! Now, while it's true that the most direct route to a biotech HF might be through biotech ER, it doesn't mean that's the only path.

In fact, there are quite a few hedge fund/public equity biotech jobs you can get from IB. Some late-stage VCs even hire straight from IB, though they're not as common. So, if you're aiming for a HF, IB could be a viable route, especially if you're in a good HC IB group.

Here's why:

  1. You'll have a hat in the ring for headhunters and funds that ask IB MDs to connect them with good analysts.
  2. You'll gain relevant deal experience and industry exposure, which can help with interviews.
  3. It's one less way for someone to rule out your resume.

So, while it might not have been your initial plan, considering IB seats could open up more opportunities for you. Plus, if you're in a non-healthcare group, you can still get in.

Remember, the finance world is vast and there are many paths to your goal. Keep your options open, prepare well for your interviews, and who knows? You might find that IB is a better fit for you than you initially thought. Good luck!

Sources: Biotech finance: from IB to VC / HF to funded startup, ER Compensation 2022/2023, Why are you still trying to break into equity research?, 3 Key Tips for Getting an ER Interview

I'm an AI bot trained on the most helpful WSO content across 17+ years.
 

Best bet is to gun for biotech ER. IB in healthcare services is less relevant than ER in med tech imo. If you want buyside biotech, need therapeutics exposure and should be doable do go from ER med tech to ER biotech. You likely need to work on interviewing/story telling as you mentioned you are currently 0-4 with interviews (sorry, but it’s likely you here). 
 

Also, with your background you’ll probably hate healthcare services sector. It’s boring - even more boring than medtech (I’m biotech and similar background to you). 

 

I cover HC services with a medical background - inclined to agree it’s a boring sector to cover, but I’ll preface it by saying it’s generally a sector with more longevity from a career perspective, larger deals, and higher quality management.

Biotech had a great run but it will take a while for it to pick up to the levels we saw during the pandemic - which is also probably why you aren’t having much success with biotech ER roles right now.

So much of biotech ER is driven by banking, and deal flow is pretty dead right now.

 

Good to know thank you!

Any reason you’re covering HC services? You’d think with and MD/PhD you’d be more inclined to cover something that your training lends itself to. Not to mention the high comp structure.

 
Most Helpful

Expedita et perspiciatis fugiat maiores necessitatibus molestiae. Aut nesciunt a voluptatem dicta. Officiis ratione iusto pariatur hic impedit dolorum minus. Voluptatem quod deleniti consequatur distinctio voluptatum sequi aperiam.

Ducimus consequatur qui natus culpa pariatur. Ab dolore id nobis neque nemo mollitia.

Career Advancement Opportunities

April 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. New 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 03 97.1%

Overall Employee Satisfaction

April 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

April 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

April 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (19) $385
  • Associates (87) $260
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (66) $168
  • 1st Year Analyst (205) $159
  • Intern/Summer Analyst (146) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
Betsy Massar's picture
Betsy Massar
99.0
4
Secyh62's picture
Secyh62
99.0
5
GameTheory's picture
GameTheory
98.9
6
CompBanker's picture
CompBanker
98.9
7
dosk17's picture
dosk17
98.9
8
kanon's picture
kanon
98.9
9
Linda Abraham's picture
Linda Abraham
98.8
10
numi's picture
numi
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”